Brief: Kymera Therapeutics Q1 EPS USD -0.71
30/04/2026 12:00
Apr 30 (Reuters) - Kymera Therapeutics Q1 revenue USD 34.365 million vs. IBES estimate USD 8.61 million. Q1 operating expenses USD 118.519 million Q1 net income USD -69.234 million
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer